MyEssentials
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1872 Kipling Ave, Toronto, Ontario, M9W ...Phone Number
(800) 474-1800Website
www.myessentials.caRevenue
<$5 MillionIndustry
About MyEssentials
Is MyEssentials your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
MyEssentials, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once MyEssentials has new funding data
Product Launch: Get notified when MyEssentials launches new products
Check out if MyEssentials is spiking on competitors!
Earning: See what the market has to say on MyEssentials recently announced quarterly report
Check if MyEssentials has recently received funding, and reach out quickly before it becomes old news!
Click to see if MyEssentials had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at MyEssentials
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined MyEssentials as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
MyEssentials is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
MyEssentials is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about MyEssentials.
MyEssentials Tech Stack
A closer look at the technologies used by MyEssentials
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding MyEssentials
Zorqalyx is a next-generation weight management therapy designed for sustained weight reduction and enhanced metabolic health. The therapy, which has completed Phase 4 trials, is set for availability in August 2026 and is intended for use under physician supervision. It features a once-weekly dosing regimen and is structured to support long-term ad... Read More